How do I appeal a health insurance denial?

You can appeal a health insurance denial by writing a formal appeal letter citing the specific reason for denial, relevant medical evidence, and applicable federal and state laws. Healthcare Watchdog's free AI tool generates a professional appeal letter in minutes, citing the exact laws and regulations your insurer may have violated.

Is this insurance appeal tool really free?

Yes, Healthcare Watchdog's AI appeal letter generator is completely free. There are no hidden fees, no paywalls, and no data sold. The platform was built by a patient who experienced insurance denial firsthand.

What types of insurance denials can I appeal?

You can appeal medical necessity denials, out-of-network denials, prior authorization denials, experimental treatment denials, and more. Our tool works for all major insurers including UnitedHealthcare, Aetna, Cigna, Blue Cross Blue Shield, and Humana.

How long do I have to appeal an insurance denial?

Appeal deadlines vary by state and insurer, typically ranging from 30 to 180 days. Under the ACA, you generally have 180 days for internal appeals and 4 months for external review. Check your specific state's deadlines on our State Rights page.

What is the success rate of insurance appeals?

Studies show that roughly 50% of insurance appeals are successful, yet fewer than 1% of denied claims are ever appealed. This means millions of people are paying for care that should have been covered. A well-written appeal letter with proper legal citations significantly increases your chances.

Back to Case Database

Settledfraud case

United States v. OptumRx - Pharmacy Benefit Manager Kickbacks

U.S. Department of Justice -- Filed August 10, 2022

View Source

How This Affects You

OptumRx settled for $90 million after paying illegal kickbacks that raised drug costs for patients. If your prescriptions were managed through OptumRx, you may have been steered toward more expensive medications to benefit the company.

Use this case in your appeal letter

Case Summary

The Department of Justice reached a $90 million settlement with OptumRx, a UnitedHealth Group subsidiary, resolving allegations that OptumRx accepted illegal kickbacks from pharmaceutical manufacturers in exchange for giving their drugs preferred formulary placement. The government alleged this scheme drove up drug costs for patients and federal healthcare programs while patients were steered toward more expensive medications without medical justification.

Original Source

Case Details

Case Number

DOJ-2022-OPTUMRX-PBM

Defendant

OptumRx

Jurisdiction

Federal

Violation Type

illegal kickbacks

Filed

August 10, 2022

Keywords

optumrxkickbackspharmacy benefit managerpbmformularyprescription drugssettlementfalse claims actpharmaceutical

Source: doj_manual

Last updated: February 19, 2026